Consideration and recommendation of Final Dividend for the FY 2025-26, subject to the approval of members at the ensuing Annual General Meeting.
Awaiting price reaction for this filing.
The Board of Directors approved the audited financial results for FY 2025-26 showing total income of Rs. 34,566.01 Lakhs, a 24% increase from Rs. 27,887.52 Lakhs in the previous year. However, the company reported a net loss of Rs. 787.40 Lakhs for the year, compared to a loss of Rs. 179.98 Lakhs in FY 2024-25. An exceptional item of Rs. 4,705.30 Lakhs was recorded due to loss on sale of investment in subsidiary Hindusthan Specialty Chemicals Limited to DCM Shriram Limited. The Board recommended a final dividend of Rs. 0.50 per equity share (25%) for FY 2025-26, subject to shareholder approval at the AGM. Additionally, a bonus issue in the ratio of 2:1 was approved, which will increase equity shares from 72,14,425 to 2,16,43,275 shares. The statutory auditors issued an unmodified opinion on the financial results.
Despite strong 24% revenue growth, the company continues to report net losses, which may concern some investors. However, the bonus issue and dividend recommendation signal management confidence, and the improved operating cash flow of Rs. 498.30 Lakhs (positive vs negative in prior year) indicates better cash generation.